Elutia Inc (ELUT)
3.74
-0.07
(-1.84%)
USD |
NASDAQ |
Oct 04, 16:00
3.74
0.00 (0.00%)
After-Hours: 20:00
Elutia SG&A Expense (TTM): 28.48M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 28.48M |
March 31, 2024 | 27.35M |
December 31, 2023 | 27.19M |
September 30, 2023 | 28.09M |
June 30, 2023 | 31.24M |
March 31, 2023 | 34.48M |
December 31, 2022 | 35.11M |
September 30, 2022 | 35.40M |
June 30, 2022 | 34.98M |
Date | Value |
---|---|
March 31, 2022 | 33.20M |
December 31, 2021 | 32.66M |
September 30, 2021 | 32.95M |
June 30, 2021 | 31.62M |
March 31, 2021 | 29.43M |
December 31, 2020 | 28.21M |
September 30, 2020 | 27.64M |
June 30, 2020 | 27.55M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
27.19M
Minimum
Dec 2023
35.40M
Maximum
Sep 2022
30.92M
Average
31.24M
Median
Jun 2023
SG&A Expense (TTM) Benchmarks
Perspective Therapeutics Inc | 18.64M |
Retractable Technologies Inc | 19.15M |
InfuSystems Holdings Inc | 59.37M |
Xtant Medical Holdings Inc | 79.82M |
Catheter Precision Inc | 10.84M |